<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02285595</url>
  </required_header>
  <id_info>
    <org_study_id>CS-06</org_study_id>
    <nct_id>NCT02285595</nct_id>
  </id_info>
  <brief_title>Sonendo GentleWave™ System for Treatment in Molar Teeth Requiring Root Canal Therapy</brief_title>
  <acronym>SUPREME</acronym>
  <official_title>A Prospective, Multicenter Study Comparing Healing After Treatment With the Sonendo GentleWave™ System as Compared to a Traditional Root Canal Therapy Literature Control</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sonendo, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sonendo, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, literature controlled, clinical study evaluating healing rates for the Sonendo
      GentleWave System in the treatment of 1st and 2nd molars indicated for root canal therapy.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">July 2014</start_date>
  <completion_date type="Actual">December 31, 2018</completion_date>
  <primary_completion_date type="Actual">June 22, 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Subject teeth that are healed or healing at the 12 month follow-up visit.</measure>
    <time_frame>12 months</time_frame>
    <description>Healed is defined by absence of a radiographic indication of apical periodontitis (PAI &lt;3) and absence of clinical signs and symptoms other than tenderness to percussion.
Healing is defined by a reduction of radiolucency (if radiolucency is present at Baseline) combined with the absence of clinical signs and symptoms other than tenderness to percussion.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Root Canal Therapy</condition>
  <arm_group>
    <arm_group_label>Sonendo GentleWave™ System</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The Sonendo GentleWave System is intended to prepare, clean, and irrigate 1st and 2nd molar teeth indicated for root canal therapy.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sonendo GentleWave™ System</intervention_name>
    <arm_group_label>Sonendo GentleWave™ System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 to 75 years of age

          -  Indicated for root canal therapy

          -  First or second molar

          -  Signed informed consent form

        Exclusion Criteria:

          -  Poor oral hygiene

          -  Class II or III mobility

          -  Open or incompletely formed root apices

          -  Vertical fracture, horizontal fracture, or perforation below the Cemento-Enamel
             Junction (CEJ)

          -  Previous pulpectomy or root canal therapy

        Note: Additional exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dan Miller</last_name>
    <role>Study Director</role>
    <affiliation>Sonendo, Inc.</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Shahriar Rassoulian, DMD</name>
      <address>
        <city>Aliso Viejo</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Khang Le, DDS</name>
      <address>
        <city>Santa Ana</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stacey Woo, DDS</name>
      <address>
        <city>Whittier</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>November 3, 2014</study_first_submitted>
  <study_first_submitted_qc>November 4, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 7, 2014</study_first_posted>
  <last_update_submitted>April 2, 2019</last_update_submitted>
  <last_update_submitted_qc>April 2, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

